Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue European Journal of Heart Failure Année : 2020

Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial

Dates et versions

hal-02865493 , version 1 (11-06-2020)

Identifiants

Citer

Johannes Petutschnigg, Joao Pedro Ferreira, Volker Holzendorf, Tobias Trippel, Djawid Hashemi, et al.. Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post‐hoc analysis of the Aldo‐DHF trial. European Journal of Heart Failure, 2020, 22 (3), pp.559-561. ⟨10.1002/ejhf.1723⟩. ⟨hal-02865493⟩
37 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More